NCT01499927

Brief Summary

Switching from intravenous application of antiinfective agents to oral therapy is often performed late including high costs and risk of complications. This study will investigate the impact of displayed reminders in the electronic patient chart after 60h of intravenous therapy with an antiinfective agent.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
74,766

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 15, 2011

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 26, 2011

Completed
6 days until next milestone

Study Start

First participant enrolled

January 1, 2012

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
Last Updated

December 19, 2013

Status Verified

December 1, 2013

Enrollment Period

11 months

First QC Date

November 15, 2011

Last Update Submit

December 18, 2013

Conditions

Keywords

Early reassessment of intravenous antiinfective therapy

Outcome Measures

Primary Outcomes (1)

  • duration of intravenous antiinfective therapy until switching

    1 year

Secondary Outcomes (5)

  • costs (per year, per day and patient)

    1 year

  • defined daily doses (per 100 days)

    1 year

  • duration of hospitalization

    1 year

  • ratio of narrow to broad-spectrum antibiotics

    1 year

  • requests for consultations

    1 year

Study Arms (2)

electronic reminders

ACTIVE COMPARATOR

Behavioral: Early switching from intravenous to oral antiinfective agents due to electronic reminders

Other: electronic reminders

no electronic reminders

NO INTERVENTION

Behavioral: Early switching from intravenous to oral antiinfective agents without computerized decision support

Interventions

Behavioral: Early switching from intravenous to oral antiinfective agents due to electronic reminders

Also known as: computerized decision support
electronic reminders

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • all in-patients in treatment with an intravenous antiinfective for \>60h,
  • hospitalized in a ward with computerized physician order entry (cpoe)

You may not qualify if:

  • outpatients,
  • ward without cpoe,
  • no intravenous antiinfective treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Zurich, Center for Clinical Research

Zurich, Canton of Zurich, 8091, Switzerland

Location

Related Publications (1)

  • Beeler PE, Kuster SP, Eschmann E, Weber R, Blaser J. Earlier switching from intravenous to oral antibiotics owing to electronic reminders. Int J Antimicrob Agents. 2015 Oct;46(4):428-33. doi: 10.1016/j.ijantimicag.2015.06.013. Epub 2015 Jul 21.

Study Officials

  • Juerg Blaser, Professor

    University Hospital Zurich, Center for Clinical Research

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 15, 2011

First Posted

December 26, 2011

Study Start

January 1, 2012

Primary Completion

December 1, 2012

Study Completion

December 1, 2012

Last Updated

December 19, 2013

Record last verified: 2013-12

Locations